Embolic Protection and Platelet Inhibition During Renal Artery Stenting | Zendy

Christopher J. Cooper | Zendy; Steven T. Haller | Zendy; William R. Colyer | Zendy; Michael W. Steffes | Zendy; Mark W. Burket | Zendy; William J. Thomas | Zendy; Robert D. Safian | Zendy; Bhagat Reddy | Zendy; Pamela Brewster | Zendy; Mary Ankenbrandt | Zendy; Renu Virmani | Zendy; Eric J. Dippel | Zendy; Krishna J. RochaSingh | Zendy; Timothy F. Murphy | Zendy; David J. Kennedy | Zendy; Joseph I. Shapiro | Zendy; Ralph D. D'Agostino | Zendy; Michael Pencina | Zendy; Sadik Khuder | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Embolic Protection and Platelet Inhibition During Renal Artery Stenting

Author(s) -

Christopher J. Cooper,

Steven T. Haller,

William R. Colyer,

Michael W. Steffes,

Mark W. Burket,

William J. Thomas,

Robert D. Safian,

Bhagat Reddy,

Pamela Brewster,

Mary Ankenbrandt,

Renu Virmani,

Eric J. Dippel,

Krishna J. RochaSingh,

Timothy F. Murphy,

David J. Kennedy,

Joseph I. Shapiro,

Ralph D. D'Agostino,

Michael Pencina,

Sadik Khuder

Publication year - 2008

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.730259

Subject(s) - medicine , renal artery , cardiology , platelet , platelet inhibition , kidney , platelet aggregation

Preservation of renal function is an important objective of renal artery stent procedures. Although atheroembolization can cause renal dysfunction during renal stent procedures, whether adjunctive use of embolic protection devices or glycoprotein IIb/IIIa inhibitors improves renal function is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research